# Christa Schorr

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christa-schorr/

## Facts

| Field | Value |
| --- | --- |
| Citations | 29,877 |
| Field | Sepsis Diagnosis and Treatment |
| h-index | 41 |
| i10-index | 75 |
| Last Known Institution | Cooper Medical School of Rowan University |
| OpenAlex ID | https://openalex.org/A5027206752 |
| ORCID iD | https://orcid.org/0000-0001-7777-4280 |
| Works | 198 |

## Researcher papers

- [Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and/)
- [Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-3/)
- [Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-2/)
- [Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021](https://scholariq.org/papers/surviving-sepsis-campaign-international-guidelines-for-management-of-sepsis-and-4/)
- [Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US](https://scholariq.org/papers/factors-associated-with-death-in-critically-ill-patients-with-coronavirus/)
- [Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19](https://scholariq.org/papers/association-between-early-treatment-with-tocilizumab-and-mortality-among/)
- [Executive Summary: Surviving Sepsis Campaign: International Guidelines for the Management of Sepsis and Septic Shock 2021](https://scholariq.org/papers/executive-summary-surviving-sepsis-campaign-international-guidelines-for-the/)
- [Characteristics and Outcomes of Individuals With Pre-existing Kidney Disease and COVID-19 Admitted to Intensive Care Units in the United States](https://scholariq.org/papers/characteristics-and-outcomes-of-individuals-with-pre-existing-kidney-disease-and/)
- [Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19](https://scholariq.org/papers/thrombosis-bleeding-and-the-observational-effect-of-early-therapeutic/)

## Researcher topics

- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [Nosocomial Infections in ICU](https://scholariq.org/topics/nosocomial-infections-in-icu/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)
- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Family and Patient Care in Intensive Care Units](https://scholariq.org/topics/family-and-patient-care-in-intensive-care-units/)

## Researcher university

- [Cooper Medical School of Rowan University](https://scholariq.org/institutions/cooper-medical-school-of-rowan-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.